Literature DB >> 300308

Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.

D A Horwitz, M A Garrett.   

Abstract

The mitogenic reactivity of lymphocytes from subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma was studied. Cultures containing either unseparated or separated lymphocytes were stimulated with phytohaemagglutinin, Con A and pokeweed mitogen after inhibitory serum factors were eluted from the cell surface. Incorporation of [3H]thymidine in patient cultures was compared to that of normal controls. Greatly decreased reactivity was found in SLE to all three mitogens. Significantly decreased values to some mitogens was also observed in rheumatoid arthritis and scleroderma, but the defect was less severe. Cultures of study subjects contained significantly fewer small lymphocytes than normal controls and this finding explained at least in part the decreased mitogenic reactivity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300308      PMCID: PMC1540894     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Aspirin and lymphocyte transformation.

Authors:  M J Smith; M Hoth; K Davis
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

2.  Dose-dependent hyporreactivity to phytohemagglutinin in systemic lupus erythematosus.

Authors:  I Malavé; Z Layrisse; M Layrisse
Journal:  Cell Immunol       Date:  1975-02       Impact factor: 4.868

3.  A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus.

Authors:  D A Horwitz; J B Cousar
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

4.  Immunoglobulin and receptors for C3 on lymphocytes from patients with rheumatoid arthritis.

Authors:  O J Mellbye; R P Messner; J R DeBord; R C Williams
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

5.  Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA).

Authors:  S R Cooperband; R C Davis; K Schmid; J A Mannick
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

6.  Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin.

Authors:  D A Horwitz; P I Lobo
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

7.  Comparative study of the in vitro proliferative responses of blood and synovial fluid leukocytes of rheumatoid arthritis patients.

Authors:  M D Reynolds; N I Abdou
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

8.  Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations.

Authors:  M D Lockshin; A C Eisenhauer; R Kohn; M Weksler; S Block; S B Mushlin
Journal:  Arthritis Rheum       Date:  1975 May-Jun

9.  Suppression of lymphocyte transformation after aspirin ingestion.

Authors:  J E Crout; B Hepburn; R E Ritts
Journal:  N Engl J Med       Date:  1975-01-30       Impact factor: 91.245

10.  Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies.

Authors:  D A Horwitz; M A Garrett; A H Craig
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

View more
  24 in total

1.  Depressed primary in vitro antibody response in rheumatoid arthritis.

Authors:  P Segond; J F Delfraissy; P Galanaud; C Wallon; P Massias; J Dormont
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

2.  The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody.

Authors:  M Blank; B Sredni; M Albeck; E Mozes; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 3.  Systemic lupus erythematosus--an autoimmune disease?

Authors:  E J Holborow
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

4.  Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes.

Authors:  L A Runge; R S Pinals; R H Tomar
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

5.  Spontaneous recovery of the decreased expression in vitro of interleukin 2 receptors in rheumatoid arthritis.

Authors:  C Plater-Zyberk; K A Rockett; R N Maini
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

Review 6.  Pathogenesis of systemic lupus erythematosus.

Authors:  C C Mok; C S Lau
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

7.  Stimulation of lymphocytes by platelet-antibody-complexes and their role in the pathogenesis of idiopathic thrombocytopenia.

Authors:  R Waldschmidt; C Mueller-Eckhardt
Journal:  Blut       Date:  1979-07

8.  Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic lupus erythematosus.

Authors:  J K Wright; P Hughes; K Gelsthorpe; A M Ward; N R Rowell
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

9.  Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.

Authors:  M Baron; E C Keystone; D D Gladman; P Lee; L Poplonski
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

10.  Naturally occurring human antibodies to the F(ab')2 portion of IgG.

Authors:  H Nasu; D S Chia; D W Knutson; E V Barnett
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.